Overview

Gender

male

Richard A. Bender has served as Signal Genetics’ Chief Medical Officer since September 2015. Prior to joining the company, from 2012 to 2015, Rich held consulting roles with various companies, including serving as a long-term medical affairs consultant for Quest Diagnostics. From 2011 to 2012, he served as Senior Vice President, Medical Affairs of Caris Life Sciences. From 2008 to 2011, Rich served as Chief Medical Officer and Vice President of Agendia, Inc. where he helped to develop advocacy, adoption and reimbursement of the company's breast cancer assays. From 2002 to 2008, he served as the Medical Director of Hematology/Oncology at Quest Diagnostics. From 2000 to 2002, he served as Senior Director/Strategic Development Leader in Medical Oncology/Hematology at Johnson & Johnson Pharmaceutical R&D. From 1982 to 2000, he served as Director of Medical Oncology/Hematology at Permanente Medical Group where he helped to manage the second largest cancer center in California. From 1972 to 1978, Rich served in various roles including Senior Investigator and Attending Physician at the National Cancer Institute in Bethesda, Maryland. He received his M.D. from the University of California, Los Angeles as a Regents Scholar and has a B.A. in Biology from the University of California, Santa Barbara.